1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional" is currently closed and not accepting applications.
Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional is sponsored by National Human Genome Research Institute (NHGRI).
This NOFO is a limited competition to support transdisciplinary ELSI research, establish ELSI research teams that include partnerships with relevant communities, build research capacity, and develop the ELSI workforce. It specifically aims to broaden the knowledge, skills, expertise, and perspectives in ELSI research and encourages engagement with communities affected by and interested in the research.
Get alerted about grants like this
Get emailed when new opportunities from “National Human Genome Research Institute (NHGRI)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
BBAER Program Opens Applications for Organizations Advancing ELSI Research in Genetics and Genomics BBAER Program Opens Applications for Organizations Advancing ELSI Research in Genetics and Genomics Applications are open for the Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional (RFA-HG-24-026).
This opportunity supports organizations interested in advancing scholarship and capacity in ELSI research related to advances in genetics and genomics. Eligible applicants must be domestic organizations located in the United States and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years (FY 2023–2025).
Eligible applicants may propose partnerships with other organizations that receive more than $30 million per year in NIH funding. Students and trainees are not eligible to apply. Organizations outside of the United States are not eligible to apply.
The goals of the Building Partnerships and Broadening Perspectives to Advance ELSI Research (BBAER) Program are to: Enhance ELSI research teams through partnerships with relevant communities Build ELSI research capacity Expand the ELSI workforce Collectively, these goals will broaden the types of knowledge, skills, expertise, experience, and perspectives brought to bear in ELSI research This program is funded by the National Human Genome Research Institute’s (NHGRI) ELSI Research Program.
Since 1990, the ELSI Research Program has funded research, research training, resource development, and other activities addressing the ethical, legal, and social implications of advances in genetics and genomics. Detailed application requirements and program information are available in the Notice of Funding Opportunity RFA-HG-24-026 , which includes an overview diagram of all application elements.
Frequently Asked Questions and a recorded program presentation are also available online. Per NIH notice NOT-OD-26-019, letters of intent are no longer required. For additional questions or to discuss organizational interests, please contact Dr. Rene Sterling at rene.
sterling@nih. gov. Notice of Funding Opportunity RFA-HG-24-026 BBAER Frequently Asked Questions BBAER Pre-Application Recorded Webinar AIM-AHEAD Research Spotlight Series: Showcasing Innovative Research Across the Consortium Find out more about how AIM-AHEAD Consortium Development Program participants Yanmin Gong (PhD) and Feifan Liu (PhD) are advancing healthcare through AI/ML-driven research.
Beyond the Program: Success Stories from the AIM-AHEAD Program for Artificial Intelligence Readiness (PAIR) Read inspiring success stories from AIM-AHEAD PAIR awardees who are building AI/ML research capacity, launching innovative labs, and creating new opportunities for students and collaborators at institutions across the country.
More than 50 AIM-AHEAD Trainees Present In-Progress Research at the Bridge2AI 2026 All-Hands Meeting April 28-29 Leading experts, researchers, trainees, and partners from across the biomedical and artificial intelligence and machine learning (AI/ML) community convened for the Bridge2AI All-Hands meeting.
According to the current listing, eligibility includes: Domestic organizations located in the United States and its territories that received less than $30 million per year in total NIH funding for the past three fiscal years (e.g., FY 2021, FY 2022, and FY 2023 for the August 2025 deadline). Partnerships with organizations receiving more than $30 million in NIH funding are allowed. Students and trainees are not eligible to apply. Organizations outside of the United States are not eligible. Confirm the full requirements in the official notice before applying.
The current listing shows approximately $4,800,000 in FY 2025 to fund up to 4 awards; application budgets limited to $650,000 direct costs per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 31, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional is funded by National Human Genome Research Institute (NHGRI). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
While headlines chase AI and defense money, USDA's National Institute of Food and Agriculture runs a tight summer competitive cycle — Equipment Grants (June 25), Agricultural Genome to Phenome (June 29), New Beginning for Tribal Students (July 2), and Crop Protection and Pest Management (July 6). Here is how the four programs fit together, who is eligible, and why the land-grant system has a structural edge.
Read articleThe STOMP program funds measurement tools and removal therapies for microplastics in human tissue. Proposals due June 22. Eligibility, phases, and strategy.
Read articleThe Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.
Read article